Table 2.
Disease model | miRNA | Source | Research results | Reference |
---|---|---|---|---|
AD | miR-34a | Rat cortical neuron-Exo | miR-34a activated synaptic linkage and proved polygenic AD formation mechanism | [58] |
AD | miR-193b | CSF and serum-Exo | Control diseases affected by amyloid precursor protein | [59] |
PD | miR-136-3p, miR-433, miR-153, miR-409-3p | CSF-Exo | miRNAs can play a significant role as biomarkers | [60] |
PD | miR-34a-5p | Plasma-Exo | miR-34a-5p is helpful in distinguishing healthy people from PD patients and in assessing depression levels | [61] |
Stroke | miR-126 | EPCs-Exo | Regulate PI3K pathway can effectively reduce cerebral infarction size and promote vascular regeneration | [62] |
Stroke | miR-17-92 | MSCs-Exo | Restore the function of nerve cells and reduce damage | [63] |
Stroke | miR-134 | Serum-Exo | Regulate inflammatory factors, infarct size and influence prognosis | [64] |
Epilepsy | miR-346 miR-331-3p |
Rat forebrain-Exo | Inhibit neurotransmitter transmission | [65] |
ALS | miR-494-3p | Astrocyte-Exo | Affect motor neuron function and induce neuron degeneration | [66] |
MS | miR-326 | CD4 + T cells-Exo | Regulate the immune response | [67] |
HD | miR-128 miR-130b-3p |
Serum and plasma-Exo | miRNAs are closely related to ageing-related diseases | [68] |
AD: Alzheimer’s disease; PD: Parkinson’s disease; ALS: amyotrophic lateral sclerosis; MS: multiple sclerosis; HD: Huntington’s disease; MSCs: mesenchymal stem cells; Exo: exosome; CSF: cerebrospinal fluid; EPCs: endothelial progenitor cells.